Cargando…

Accumulation of (123)I-Ioflupane Is a Useful Marker of the Efficacy of Selegiline Monotherapy in Drug-Naïve Parkinson’s Disease

Background: Selegiline enhances the patient’s endogenous dopamine by inhibiting dopamine metabolism. The efficacy of selegiline monotherapy for drug-naïve Parkinson’s disease (PD) patients may depend on the degree of dopaminergic neuronal degeneration. (123)I-Ioflupane single photon emission compute...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murakami, Hidetomo, Nohara, Tetsuhito, Uchiyama, Masanobu, Owan, Yoshiyuki, Futamura, Akinori, Shiromaru, Azusa, Tsukada, Setsuro, Saito, Yu, Kuroda, Takeshi, Yano, Satoshi, Ishigaki, Seiichiro, Katoh, Hirotaka, Munechika, Jiro, Ohgiya, Yoshimitsu, Gokan, Takehiko, Ono, Kenjiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626819/ https://www.ncbi.nlm.nih.gov/pubmed/29033831 http://dx.doi.org/10.3389/fnagi.2017.00321

Ejemplares similares

High serum high-density lipoprotein-cholesterol is associated with memory function and gyrification of insular and frontal opercular cortex in an elderly memory-clinic population
por: Kinno, Ryuta, et al.
Publicado: (2019)

Usefulness Differs Between the Visual Assessment and Specific Binding Ratio of (123)I-Ioflupane SPECT in Assessing Clinical Symptoms of Drug-Naïve Parkinson’s Disease Patients
por: Murakami, Hidetomo, et al.
Publicado: (2018)

The subjective perception of past, present, and future time in patients with Alzheimer’s disease: a qualitative study
por: Shiromaru-Sugimoto, Azusa, et al.
Publicado: (2018)

MR Imaging of Fetuses to Evaluate Placental Insufficiency
por: OHGIYA, Yoshimitsu, et al.
Publicado: (2015)

Differential Effects of the Factor Structure of the Wechsler Memory Scale-Revised on the Cortical Thickness and Complexity of Patients Aged Over 75 Years in a Memory Clinic Setting
por: Kinno, Ryuta, et al.
Publicado: (2017)

Effects of dopaminergic drug adjustment on executive function in different clinical stages of Parkinson’s disease
por: Murakami, Hidetomo, et al.
Publicado: (2017)

Intracardiac Thrombosis and Heart Failure in a Patient with Hepatocellular Carcinoma and Cardiac Amyloidosis and an Implanted Cardiac Resynchronization Therapy Device
por: Akutsu, Yasushi, et al.
Publicado: (2019)

The clinical impact of MRI screening for BRCA mutation carriers: the first report in Japan
por: Murakami, Wakana, et al.
Publicado: (2019)

Selegiline: a molecule with innovative potential
por: Tábi, Tamás, et al.
Publicado: (2019)

Dysfunctional counting of mental time in Parkinson’s disease
por: Honma, Motoyasu, et al.
Publicado: (2016)

Impaired cognitive modification for estimating time duration in Parkinson’s disease
por: Honma, Motoyasu, et al.
Publicado: (2018)

The Cerebellar Leptomeningeal Enhancement Associated with Cryptococcal Meningitis
por: Shiromaru, Azusa, et al.
Publicado: (2018)

Singular case of the driving instructor: Temporal and topographical disorientation
por: Futamura, Akinori, et al.
Publicado: (2017)

Transdermal selegiline for the treatment of major depressive disorder
por: Lee, Kelly C, et al.
Publicado: (2007)

Effects on Sperms’ Quality of Selegiline in Aged Rats
por: Kalász, Huba, et al.
Publicado: (2017)

CT-Based Attenuation Correction in I-123-Ioflupane SPECT
por: Lange, Catharina, et al.
Publicado: (2014)

Agraphia of the left hand with dysfunction of the left superior parietal region without callosal lesions
por: Kinno, Ryuta, et al.
Publicado: (2018)

Selegiline reduces daytime sleepiness in patients with Parkinson's disease
por: Gallazzi, Marco, et al.
Publicado: (2021)

Striking Neurochemical and Behavioral Differences in the Mode of Action of Selegiline and Rasagiline
por: Harsing, Laszlo G., et al.
Publicado: (2023)

Patient Survey on Satisfaction and Impact of 123I-Ioflupane Dopamine Transporter Imaging
por: Covington, Matthew F., et al.
Publicado: (2015)

Interpreting (123)I–ioflupane dopamine transporter scans using hybrid scores
por: Nichols, Kenneth J., et al.
Publicado: (2018)

A new visual rating scale for Ioflupane imaging in Lewy body disease
por: Lloyd, Jim J., et al.
Publicado: (2018)

Safety, biodistribution and radiation dosimetry of [(123)I]ioflupane in healthy Chinese volunteers
por: Zhang, Min, et al.
Publicado: (2023)

Contraction of distance and duration production in autism spectrum disorder
por: Honma, Motoyasu, et al.
Publicado: (2019)

Increased Presence of Cerebral Microbleeds Correlates With Ventricular Enlargement and Increased White Matter Hyperintensities in Alzheimer’s Disease
por: Kuroda, Takeshi, et al.
Publicado: (2020)

Adjuvant Potential of Selegiline in Attenuating Organ Dysfunction in Septic Rats with Peritonitis
por: Tsao, Cheng-Ming, et al.
Publicado: (2014)

Monitoring the Level of (14)C-Labelled Selegiline Following Oral Administration
por: Kalász, Huba, et al.
Publicado: (2017)

Effect of Combined Electroacupuncture and Selegiline Treatment in Alzheimer’s Disease: An Animal Model
por: Cai, Mudan, et al.
Publicado: (2020)

Discriminating among degenerative parkinsonisms using advanced (123)I-ioflupane SPECT analyses
por: Badoud, Simon, et al.
Publicado: (2016)

Diagnosis of Parkinson syndrome and Lewy-body disease using (123)I-ioflupane images and a model with image features based on machine learning
por: Nakajima, Kenichi, et al.
Publicado: (2022)

Long-term Monitoring Gait Analysis Using a Wearable Device in Daily Lives of Patients with Parkinson’s Disease: The Efficacy of Selegiline Hydrochloride for Gait Disturbance
por: Iijima, Mutsumi, et al.
Publicado: (2017)

Bipolar Disorder and Parkinson's Disease: A (123)I-Ioflupane Dopamine Transporter SPECT Study
por: Erro, Roberto, et al.
Publicado: (2021)

Rest Tremor Pattern Predicts DaTscan ( (123)I‐Ioflupane) Result in Tremulous Disorders
por: Quattrone, Andrea, et al.
Publicado: (2021)

Neuroprotective Effects of Meloxicam and Selegiline in Scopolamine-Induced Cognitive Impairment and Oxidative Stress
por: Goverdhan, Puchchakayala, et al.
Publicado: (2012)

Comparison of Selegiline and Rasagiline Therapies in Parkinson Disease: A Real-life Study
por: Peretz, Chava, et al.
Publicado: (2016)

Improvement of Movement Disorder and Neurodevelopment under Selegiline in a CLTC‐Deficient Patient
por: Nardecchia, Francesca, et al.
Publicado: (2023)

Comparison between Different Intensity Normalization Methods in (123)I-Ioflupane Imaging for the Automatic Detection of Parkinsonism
por: Brahim, A., et al.
Publicado: (2015)

Effect of selegiline on neural stem cells differentiation: a possible role for neurotrophic factors
por: Hassanzadeh, Kambiz, et al.
Publicado: (2015)

Selegiline improves excessive daytime sleepiness in Parkinson's disease: an open-label observational study
por: Zhang, Jinru, et al.
Publicado: (2022)

Low Dose Betahistine in Combination With Selegiline Increases Cochlear Blood Flow in Guinea Pigs
por: Kloos, Benedikt, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qhab17ru3udf8vutree3v2ooi4